Of the CD10+ populations, the residual lymphoid cell subpopulations with a stable or increased percentage in common ALL patients with BCR/ABL+ were obviously reduced compared to those in the BCR/ABL− patients (Fig. 4). Here, ABL1 is linked to acute lymphoblastic leukemia.